PT1017377E - Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina - Google Patents

Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina

Info

Publication number
PT1017377E
PT1017377E PT98946704T PT98946704T PT1017377E PT 1017377 E PT1017377 E PT 1017377E PT 98946704 T PT98946704 T PT 98946704T PT 98946704 T PT98946704 T PT 98946704T PT 1017377 E PT1017377 E PT 1017377E
Authority
PT
Portugal
Prior art keywords
substituted
cylochine
aminotetralins
utilization
treatment
Prior art date
Application number
PT98946704T
Other languages
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1017377E publication Critical patent/PT1017377E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT98946704T 1997-09-22 1998-09-18 Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina PT1017377E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000569A IT1294932B1 (it) 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Publications (1)

Publication Number Publication Date
PT1017377E true PT1017377E (pt) 2002-04-29

Family

ID=11405258

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98946704T PT1017377E (pt) 1997-09-22 1998-09-18 Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina

Country Status (17)

Country Link
US (1) US6242497B1 (pt)
EP (1) EP1017377B1 (pt)
JP (1) JP2001517618A (pt)
KR (1) KR20010030670A (pt)
CN (1) CN1276721A (pt)
AT (1) ATE209910T1 (pt)
AU (1) AU735369B2 (pt)
BR (1) BR9812489A (pt)
CA (1) CA2303918A1 (pt)
DE (1) DE69802828T2 (pt)
DK (1) DK1017377T3 (pt)
ES (1) ES2167942T3 (pt)
IT (1) IT1294932B1 (pt)
MX (1) MXPA00002774A (pt)
NZ (1) NZ503391A (pt)
PT (1) PT1017377E (pt)
WO (1) WO1999015160A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
US20120208892A1 (en) 2009-10-16 2012-08-16 Epiomed Therapeutics, Inc. Emesis treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
NZ503391A (en) 2001-06-29
JP2001517618A (ja) 2001-10-09
DE69802828D1 (de) 2002-01-17
EP1017377B1 (en) 2001-12-05
EP1017377A2 (en) 2000-07-12
DE69802828T2 (de) 2002-07-18
KR20010030670A (ko) 2001-04-16
AU735369B2 (en) 2001-07-05
CA2303918A1 (en) 1999-04-01
IT1294932B1 (it) 1999-04-23
MXPA00002774A (es) 2002-10-31
US6242497B1 (en) 2001-06-05
AU9366198A (en) 1999-04-12
ATE209910T1 (de) 2001-12-15
WO1999015160A3 (en) 1999-05-20
ITRM970569A1 (it) 1999-03-22
DK1017377T3 (da) 2002-03-04
BR9812489A (pt) 2000-09-26
ES2167942T3 (es) 2002-05-16
WO1999015160A2 (en) 1999-04-01
CN1276721A (zh) 2000-12-13

Similar Documents

Publication Publication Date Title
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
EA199800667A1 (ru) Новые фенантридины
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ID23374A (id) Halogenopirimidin
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
PT901374E (pt) Tetra-hidropteridinas e piridilpiperazinas para o tratamento de disturbios neurologicos
ITRM940150A0 (it) Procedimento per il trattamento di acque di scarico fortemente colorate.
FI953717L (fi) 4-Hydroksibentsopyran-2-oneja ja 4-hydroksisykloalkyyli(b)pyran-2-oneja, joita voidaan käyttää retrovirusinfektioiden hoitamiseen
IT8721618A0 (it) Prodecimento per la depurazione bilogica di acque reflue.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
IT1285770B1 (it) Composti corticoidei
TR199900505T2 (pt)
PT977716E (pt) Utilizacao de alcoois como aditivos para rebocos e/ou argamassas
BG100248A (bg) Инхибитори на скваленсинтетаза
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
TR199802504T2 (xx) N�rotoksik yaralanmalar�n tedavisi i�in bukminsterflirin kullan�lmas�.
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
PE20399A1 (es) Muteina ob
ES2006422B3 (es) Procedimiento e instalacion para tratar la superficie de objetos.